Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D M Israelski

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Journal of Acquired Immune Deficiency Syndromes|April 1, 1993
Prevalence of Toxoplasma infection in a cohort of homosexual men at risk of AIDS and toxoplasmic encephalitisD M Israelski, J S Chmiel, L Poggensee, et al.
AIDS (London, England)|November 1, 1991
Toxoplasma serology, parasitemia and antigenemia in patients at risk for toxoplasmic encephalitisB R Dannemann, D M Israelski, G S Leoung, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 1, 1989
Treatment with anti-L3T4 (CD4) monoclonal antibody reduces the inflammatory response in toxoplasmic encephalitisD M Israelski, F G Araujo, F K Conley, et al.
Journal of Clinical Microbiology|December 1, 1988
Diagnosis of toxoplasmic encephalitis in patients with acquired immunodeficiency syndrome by using a new serologic methodY Suzuki, D M Israelski, B R Dannemann, et al.
AIDS Care|March 17, 2007
Psychiatric co-morbidity in vulnerable populations receiving primary care for HIV/AIDSD M Israelski, D E Prentiss, S Lubega, et al.
Journal of Acquired Immune Deficiency Syndromes|January 1, 1992
Plasma viremia in human immunodeficiency virus infection: relationship to stage of disease and antiviral treatmentD A Katzenstein, M Holodniy, D M Israelski, et al.
AIDS (London, England)|June 21, 2001
Phenotypic hypersusceptibility to non-nucleoside reverse transcriptase inhibitors in treatment-experienced HIV-infected patients: impact on virological response to efavirenz-based therapyN Shulman, A R Zolopa, D Passaro, et al.
Archives of Internal Medicine|July 1, 1988
Toxoplasma peritonitis in a patient with acquired immunodeficiency syndromeD M Israelski, G Skowron, J P Leventhal, et al.
AIDS Research and Human Retroviruses|February 1, 1992
Intracellular glutathione levels in T cell subsets decrease in HIV-infected individualsF J Staal, M Roederer, D M Israelski, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|March 1, 1991
Treatment of acute toxoplasmosis with intravenous clindamycin. The California Collaborative Treatment GroupB R Dannemann, J A McCutchan, D M Israelski, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Journal of Acquired Immune Deficiency Syndromes|April 1, 1993
Prevalence of Toxoplasma infection in a cohort of homosexual men at risk of AIDS and toxoplasmic encephalitisD M Israelski, J S Chmiel, L Poggensee, et al.
AIDS (London, England)|November 1, 1991
Toxoplasma serology, parasitemia and antigenemia in patients at risk for toxoplasmic encephalitisB R Dannemann, D M Israelski, G S Leoung, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 1, 1989
Treatment with anti-L3T4 (CD4) monoclonal antibody reduces the inflammatory response in toxoplasmic encephalitisD M Israelski, F G Araujo, F K Conley, et al.
Journal of Clinical Microbiology|December 1, 1988
Diagnosis of toxoplasmic encephalitis in patients with acquired immunodeficiency syndrome by using a new serologic methodY Suzuki, D M Israelski, B R Dannemann, et al.
AIDS Care|March 17, 2007
Psychiatric co-morbidity in vulnerable populations receiving primary care for HIV/AIDSD M Israelski, D E Prentiss, S Lubega, et al.
Journal of Acquired Immune Deficiency Syndromes|January 1, 1992
Plasma viremia in human immunodeficiency virus infection: relationship to stage of disease and antiviral treatmentD A Katzenstein, M Holodniy, D M Israelski, et al.
AIDS (London, England)|June 21, 2001
Phenotypic hypersusceptibility to non-nucleoside reverse transcriptase inhibitors in treatment-experienced HIV-infected patients: impact on virological response to efavirenz-based therapyN Shulman, A R Zolopa, D Passaro, et al.
Archives of Internal Medicine|July 1, 1988
Toxoplasma peritonitis in a patient with acquired immunodeficiency syndromeD M Israelski, G Skowron, J P Leventhal, et al.
AIDS Research and Human Retroviruses|February 1, 1992
Intracellular glutathione levels in T cell subsets decrease in HIV-infected individualsF J Staal, M Roederer, D M Israelski, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|March 1, 1991
Treatment of acute toxoplasmosis with intravenous clindamycin. The California Collaborative Treatment GroupB R Dannemann, J A McCutchan, D M Israelski, et al.
Pageof 3